# Review dispositions

The standard fresh-context review of `deb3f58c8a16b27ec06bc6a620aa908f0b1c3c3f` reported one blocker and no independently valuable follow-up finding. The UI displayed product and relevant-test withdrawal controls during `clarify`, while the authoritative service correctly allowed withdrawal only during `output`.

Commit `5c2bc5a` separated entity-withdrawal eligibility from direct fact editing and added browser assertions that neither control appears on resolved entities during the medication showcase's reachable serious-outcomes clarification stage. Typecheck, all 143 tests, production build, diff check, and the full 21-call predetermined Playwright suite passed after the fix.

The policy-authorized targeted recheck in the same reviewer session inspected the complete two-file remediation delta and current control/service wiring. It found the blocker resolved and reported no new blocking or independently valuable follow-up finding.
